Gastric Cancer Clinical Trials in Rennes
2 recruitingRennes, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled284 locationsNCT06764875
Recruiting
Phase 2
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group120 enrolled37 locationsNCT06253611